Ligand validation:6JLL

LMG: 1,2-DISTEAROYL-MONOGALACTOSYL-DIGLYCERIDE

LMG is a Ligand Of Interest in 6JLL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JLL_LMG_B_622	84%	48%	0.068	0.943	0.93	1.08	2	4	1	0	93%	1
6JLL_LMG_j_101	77%	52%	0.083	0.934	0.92	0.94	2	4	3	0	93%	1
6JLL_LMG_D_412	76%	51%	0.091	0.94	0.89	1	2	3	2	0	93%	1
6JLL_LMG_b_630	76%	50%	0.079	0.927	0.91	1.03	2	4	2	0	93%	1
6JLL_LMG_a_415	66%	46%	0.09	0.908	0.9	1.17	2	4	4	0	93%	1
6JLL_LMG_A_422	65%	46%	0.094	0.906	0.94	1.13	2	5	6	0	93%	1
6JLL_LMG_C_519	61%	50%	0.097	0.896	0.96	0.98	2	3	3	0	93%	1
6JLL_LMG_c_522	57%	47%	0.102	0.888	0.91	1.13	2	5	2	0	93%	1
6JLL_LMG_c_523	44%	43%	0.114	0.853	0.96	1.22	2	8	1	0	93%	1
6JLL_LMG_C_520	36%	47%	0.119	0.821	0.96	1.1	2	2	3	0	93%	1
6JLL_LMG_Z_101	29%	40%	0.138	0.851	0.95	1.38	2	6	3	0	67%	1
6JLL_LMG_z_101	25%	43%	0.14	0.824	1.07	1.13	2	4	4	0	71%	1
5GTI_LMG_m_101	91%	46%	0.054	0.954	0.89	1.17	2	6	0	0	93%	1
5V2C_LMG_B_621	91%	30%	0.074	0.972	1.09	1.67	4	8	0	0	93%	1
6JLP_LMG_M_101	85%	48%	0.069	0.946	0.92	1.08	2	4	3	0	93%	1
5WS6_LMG_j_101	84%	48%	0.077	0.952	0.88	1.14	2	5	0	0	93%	1
6JLJ_LMG_M_101	84%	49%	0.07	0.944	0.94	1.02	2	3	2	0	93%	1
7M78_LMG_B_849	99%	46%	0.056	0.986	0.71	1.37	1	8	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.